XML 66 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Warrants
12 Months Ended
Oct. 31, 2021
Warrants.  
Warrants

20.

Warrants

    

    

    

    

    

Weighted

    

Number of 

Warrants

Derivative

Weighted

average

warrants

amount

liability

average

number of

Expiry dates

 amount

exercise price

years to

expiry

 

#

 

$

 

$

 

$

 

 

Opening balance, November 1, 2019

 

43,677,333

 

6,609

 

-

 

0.6083

 

1.13

 

  

Re-class warrants on convertible debt to equity

 

-

 

(660)

 

-

 

-

 

-

 

  

Issued warrants for services (i)

 

300,000

 

64

 

-

 

0.3800

 

-

 

September 3, 2021

Issued warrants for services (ii)

 

3,500,000

 

204

 

-

 

0.3000

 

0.01

 

November 12, 2021

Issued warrants for services (iii)

 

1,000,000

 

111

 

-

 

0.3000

 

-

 

November 12, 2021

Issued warrants on convertible debt November 14, 2019

 

7,936,507

 

80

 

-

 

0.5000

 

0.03

 

November 14, 2021

Issued warrants on convertible debt December 4, 2019

 

8,392,857

 

109

 

-

 

0.5000

 

0.04

 

December 4, 2021

Issued warrants on convertible debt December 14, 2019

 

7,936,508

 

135

 

-

 

0.5000

 

0.04

 

December 12, 2021

Issued warrants for acquisition - Saturninus

 

3,750,000

 

100

-

0.4000

0.02

January 26, 2022

Issued warrants on convertible debt January 6, 2020

 

58,823,529

 

-

266

0.2550

0.30

December 31, 2021

Issued warrants on debt September 14, 2020

 

1,600,000

 

55

-

0.3000

0.01

September 30, 2021

Warrants terminated

 

(1,600,000)

(105)

-

-

-

  

Warrants expired

 

(4,252,620)

(906)

-

-

-

  

Balance October 31, 2020

 

131,064,114

5,796

266

0.4159

2.07

  

Issued warrants for acquisition - Meta

 

741,600

3

-

1.3110

-

December 14, 2021

Issued warrants for acquisition - Meta

 

40,076,411

2,616

-

0.3520

0.49

February 6, 2023

Issued warrants for acquisition - Meta

 

4,120,000

120

-

1.1040

0.06

April 11, 2023

Issued warrants on convertible debt January 6, 2020

 

-

-

11,697

-

-

December 31, 2022

Warrants issued - equity financing

 

27,878,919

6,210

-

0.5800

0.55

February 22, 2024

Warrants issued - equity financing

 

21,207,720

3,546

-

12.2500

0.03

May 26, 2024

Warrants cancelled or expired

 

(59,578,382)

(5,457)

-

-

-

Warrants exercised

 

(54,268,198)

(2,110)

(10,270)

-

-

Balance October 31, 2021

 

111,242,184

10,724

1,693

2.5995

2.01

  

As at October 31, 2021, 111,242,184 warrants were exercisable, on a basis of 15 warrants for 1 common share, with the exception of warrants issued through the acquisition of META, which were exercisable on a basis of 18.2 warrants for 1 common share.

i)

The Company issued 300,000 warrants for business development consultancy. Fifteen warrants will allow the holder to acquire one common share at $0.38 per warrant. The warrants were valued at $64 using the Black-Scholes model, as the fair value of the services provided cannot be measured reliably and the following assumptions were used: stock price of $0.37 pre-consolidation; expected life of two years; $nil dividends; expected volatility of 111% based on comparable companies; exercise price of $0.38; and a risk-free interest rate of 1.6%.

ii)

The Company issued 3,500,000 warrants for business development consultancy. Fifteen warrants will allow the holder to acquire one common share at $0.30 per warrant. The warrants were valued at $204 using the Black-Scholes model, as the fair value of the services provided cannot be measured reliably and the following assumptions were used: stock price of $0.22 pre-consolidation; expected life of two years; $nil dividends; expected volatility of 70% based on comparable companies; exercise price of $0.30; and a risk-free interest rate of 1.6%.

iii)

The Company issued 1,000,000 warrants for business development consultancy. Fifteen warrants will allow the holder to acquire one common share at $0.30 per warrant. The warrants were valued at $111 using the Black-Scholes model, as the fair value of the services provided cannot be measured reliably and the following assumptions were used: stock price of $0.22 pre-consolidation; expected life of two years; $nil dividends; expected volatility of 111% based on comparable companies; exercise price of $0.30; and a risk-free interest rate of 1.6%.

iv)

The Company measured the derivative liability to be $1,693 and recognized $6,410 as a loss on revaluation of derivative liability in the statement of net loss and comprehensive loss for the year ended October 31, 2021.